Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic


      News provided by

      Fosun

      Jan 31, 2023, 02:45 ET

      Share this article

      Share this article


      HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on 9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donate RMB100 million worth of Azvudine tablets, the oral medication for COVID-19, helping the grassroots to weather the epidemic. As of 29 January 2023, under the campaign of "A Healthy Winter Action", a total of 173,200 bottles of Azvudine tablets have been donated to 116 counties in 19 provinces, municipalities, and autonomous regions, including Yunnan, Tibet, Xinjiang, Hainan, Anhui, Jiangxi, Ningxia, Sichuan, Chongqing, and Heilongjiang. Azvudine tablets, the first domestically developed small molecule medication for COVID-19 has helped at least 150,000 villagers get through the epidemic more safely, most of whom were seniors over 65.

      Since its inception, "A Healthy Winter Action" has faced two major challenges. First, how to deliver materials to the grassroots during the peak-travel period of Spring Festival? Second, how to accurately distribute medicines to the villagers who are in need of medicine?

      While negotiating cooperation with SF Express, Fosun Foundation urgently recruited nearly a hundred employee volunteers within Fosun and its subsidiaries. Coordinating with their plan of returning home during the Spring Festival, the volunteers personally delivered medication to the donated counties.

      In addition to Fosun employee volunteers, SF Express also fully supported the donation. The delivery of medication did not stop during the Spring Festival. Guo Shuai, Assistant Secretary-General and Project Director of Fosun Foundation, stayed in the office throughout the Spring Festival to make sure that the materials are dispatched to SF Express's transshipment warehouse immediately, and then delivered by air.

      How to make sure that the most urgently needed villagers can receive medication in time? According to Ning Guang, Consultant of the COVID-19 Prevention and Control Expert Committee of the Rural Doctors Program and President of Ruijin Hospital affiliated with Shanghai Jiaotong University School of Medicine, "Rural doctors must have medicine in their hands, and the grassroots people must receive medicine in time". Fosun Foundation first covered the 72 counties in the Rural Doctors Program which has been running for five years, and delivered as much medicine as possible to rural doctors through the health department before the Spring Festival.

      On 16 January, the first batch of 600 bottles of Azvudine tablets donated to Lancang County, Yunnan Province was delivered by Zhao Zhong, a resident member of the Rural Doctors Program, to the township hospital of Lancang County, and then to the village clinics. Zhong Liping, a rural doctor in Yanyin Village, Sakai Township, received a message from villager Zhong Asuo on the morning of the fifth day of the Chinese New Year, "Thank you for the Azvudine tablets sent by Fosun Foundation before Chinese New Year. My father felt much better the next day after taking the medicine." Before taking Azvudine tablets, Zhong Asuo's 87-year-old father had fever, cough and other symptoms. When she learned that Fosun Foundation had donated to Lancang County, Zhong Liping immediately thought of distributing medicine to the elderly. Zhong Liping said, "It is this kind of feedback that makes me realize the importance of being a rural doctor."

      In order to improve the diagnostic skills of rural doctors, Fosun Foundation and Shanghai Guangci Translational Medical Research Foundation jointly established an expert committee led by Chen Erzhen, Vice President of Ruijin Hospital. Medical experts from more than 20 provinces provided targeted training for rural doctors in the form of recorded courses and Q&A sessions. Relevant training has been launched on the app of Fosun Health and People's Good Doctor. So far, more than 15,000 rural doctors have received the training online. On 13 January, with the organization of the Guizhou Provincial Health Commission and Fosun Foundation, Zhang Wenhong, a member of the expert committee, Director of the National Medical Center for Infectious Diseases, and Professor of Huashan Hospital affiliated to Fudan University, conducted a special online training for rural doctors in Guizhou.

      Along with the medicine, 37 care packages worth RMB150,000 were sent to the grassroots, which contained medical supplies that were in short supply at the grassroots, such as oximeters, oxygen concentrators, face masks, and nitrile gloves. These packages were donated by public welfare partners including Industrial and Commercial Bank of China, the New Social Stratum "New Philanthropy Program" under the United Front Work Department of CPC Central Committee, Shanghai Pudong Development (Group) Co., Ltd., Taiping Pension Co., Ltd., YouChange China Social Entrepreneur Foundation, Pingdingshan Volunteers Association, Chengdu Charity Federation, S.F. Express Group (Shanghai) Co., Ltd., Yeswood, Wuxi Qicheng Industrial Co., Ltd., Institute of Innovations, Tongxinhui, Xinjiang Juchen Law Firm, Jiangsu No. 33 Business Management Co., Ltd., Wuxi Yushou Medical Appliances Co., Ltd., Shanghai Tuyue Business Advisory Co., Ltd., Power Construction Corporation of China, and Shanghai Charity Foundation Xuhui District Representative Office Ningguo Temple 456 Cultural Special Fund, and benevolent enterprises of ONE Fosun such as Shede Spirits, Jinhui Liquor, Hainan Mining, and Golte.

      In addition, in order to strengthen the digital capability of primary healthcare institutions, Shanghai Aitrox Technology Co. Ltd., a subsidiary of Fosun, donated digital imaging systems, digital ultrasound systems and refined operation services to primary township hospitals, covering 10 township hospitals by the end of April this year, with the first batch of donations amounting to approximately RMB5 million.

      On 28 January 2023, the first day of work, the project team resumed regular meetings twice a day. At the regular meeting that night, Chen Qiyu, Co-CEO of Fosun International, said, "We have completed half of the RMB100 million medicine donation, and reached 2/3 of the goal of donating to 180 counties. We must continue to race against the virus and prepare for the next wave of infection peaks. For example, we must cover at least another 20 counties in the Tibet Autonomous Region; we must focus on protecting the elderly in cities below the third tier and in rural nursing homes. The donation of about 400,000 bottles of Azvudine tablets worth RMB100 million jointly initiated by Fosun and Genuine Biotech has been considered to be the largest public welfare donation of medicine in recent years. We hope play its due role in the revitalization of Chinese rural areas and the construction of a healthy China."

      SOURCE Fosun

      Modal title

      Also from this source

      Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal

      On 5 November 2026, Hong Kong Economic Journal (HKEJ), one of Hong Kong's most influential Chinese financial publications, hosted the "ESG &...

      Fosun Marks Ninth Year at CIIE, Guo Guangchang Calls for Bringing More Innovation to China and Taking Chinese Innovation Global

      On 5 November 2026, the 9th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center (Shanghai). This year's...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      Biotechnology

      Biotechnology

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.